MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of...
$226,200K
Proceeds from sale of
short-term investments
$70,163K
Net cash provided by
/ (used in)...
$69,750K
Canceled cashflow
$226,613K
Net increase
(decrease) in cash and cash...
$11,585K
Canceled cashflow
$58,165K
Purchase of
held-to-maturity investments
$146,258K
Acquisitions, net of cash
acquired
$66,535K
Purchase of property and
equipment, net of proceeds...
$9,595K
Cash transfer from
sale of business
$2,810K
Capitalized software
development costs
$1,415K
Net income / (loss)
$41,347K
Stock-based compensation
$17,832K
Depreciation and
amortization
$8,185K
Realized loss from sale of
short-term investments
-$5,195K
Accounts payable and
accrued expenses
$2,378K
Deferred revenue
$1,684K
Impairment of property and
equipment
$1,673K
Change in fair value of
assets and other...
$1,037K
Other non-current
assets
-$666K
Other
$471K
Deferred tax expense
(benefit)
$432K
Proceeds from the
exercise of common stock...
$193K
Net cash used in
operating activities
-$48,914K
Net cash used in
financing activities
-$8,912K
Effect of foreign
exchange rate changes on...
-$339K
Canceled cashflow
$80,900K
Canceled cashflow
$193K
Gain on sale of
business
$56,996K
Taxes paid related to
net share...
$9,105K
Acquisition consideration
allocated to seller...
$44,339K
Accounts receivable
$12,034K
Transaction costs paid
related to sale of...
$7,381K
Change in fair value of
warrant liabilities
-$4,278K
Accretion of interest
income on...
$2,214K
Prepaid expenses and
other current assets
$1,686K
Realized foreign
exchange gain
$798K
Operating right-of-use
assets/lease liabilities
$88K
Back
Back
Cash Flow
source: myfinsight.com
Strata Critical Medical, Inc. (SRTAW)
Strata Critical Medical, Inc. (SRTAW)